Current filters:
Add Filter:


Customise results display
Item hits:
Issue DateTitleAuthor(s)
2011-08-01Decisions for lung cancer chemotherapy: The influence of physician and patient factorsDavidson, PM; Jiwa, M; Goldsmith, AJ; McGrath, SJ; Digiacomo, M; Phillips, JL; Agar, M; Newton, PJ; Currow, DC
2016-11-01Anticholinergic Drug Burden in Noncancer Versus Cancer Patients Near the End of LifeHochman, MJ; Kamal, AH; Wolf, SP; Samsa, GP; Currow, DC; Abernethy, AP; LeBlanc, TW
2015-01-01Polypharmacy in patients with advanced cancer and the role of medication discontinuationLeBlanc, TW; McNeil, MJ; Kamal, AH; Currow, DC; Abernethy, AP
2017-01-01A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)Schloss, JM; Colosimo, M; Airey, C; Masci, P; Linnane, AW; Vitetta, L
2017-04-13Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature reviewSchloss, J; Colosimo, M; Vitetta, L
2019-04-01Measuring Survival Benefit in Health Technology Assessment in the Presence of Nonproportional HazardsMonnickendam, G; Zhu, M; McKendrick, J; Su, Y
2020-08A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients.Phillips-Chavez, C; Watson, M; Coward, J; Schloss, J
2021-01Extracellular Vesicles in Chemoresistance.De Rubis, G; Bebawy, M
2022-10Intraductal delivery of nanocarriers for ductal carcinoma in situ treatment: a strategy to enhance localized delivery.Pandey, M; Wen, PX; Ning, GM; Xing, GJ; Wei, LM; Kumar, D; Mayuren, J; Candasamy, M; Gorain, B; Jain, N; Gupta, G; Dua, K
2018-03Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by the chelator, Dp44mT.Moussa, RS; Kovacevic, Z; Bae, D-H; Lane, DJR; Richardson, DR
Results 1-10 of 26 (Search time: 0.014 seconds).